Key result
Cardiac troponin elevation during chemotherapy identifies patients at risk for myocardial dysfunction, in whom angiotensin-converting enzyme inhibitors like enalapril improve clinical outcomes.
Answers are grounded in this paper and cite their sources.
Cardiac troponin monitoring allows for early detection of chemotherapy-induced cardiotoxicity, enabling targeted cardioprotective therapy with ACE inhibitors to improve clinical outcomes before functional impairment occurs.
Cardiotoxicity is a frequent and serious adverse effect of both conventional and novel anticancer treatments, affecting patient survival and quality of life. The current standard for cardiac monitoring during cancer therapy, mainly based on left ventricular ejection fraction assessment, detects myocardial damage only when a functional impairment has already occurred, not allowing for early preventive strategies. Measurement of cardiospecific biomarkers has proven to have higher prognostic value than imaging modalities. In particular, cardiac troponin elevation during chemotherapy allows the identification of patients who are more prone to develop myocardial dysfunction and cardiac events during follow-up. In these patients, the use of an angiotensin-converting enzyme inhibitor such as enalapril has shown to be effective in improving clinical outcome, giving the chance for a cardioprotective strategy in a selected population. Once left ventricular dysfunction occurs, heart failure therapies currently used for other forms of left ventricular dysfunction, particularly angiotensin-converting enzyme inhibitors and β-blockers, seem to be effective. However, their use in cancer patients is still undervalued.
No takes yet. Share an insight, caveat, or question.
Colombo et al. (2012) conducted a review in Cardiotoxicity in cancer. Cardiac biomarkers and cardioprotective therapy was evaluated. Cardiac troponin elevation during chemotherapy identifies patients at risk for myocardial dysfunction, in whom angiotensin-converting enzyme inhibitors like enalapril improve clinical outcomes.
Synapse has enriched 10 related papers. Consider them for comparative context: